subject: CHEBI:94366

object_name: Tinea faciei


subject: CHEBI:94366

subject_name: itraconazole

object_name: tinea cruris

tested_intervention: unsure


subject: CHEBI:9448

subject_name: Terbinafine

object_name: dermatophytosis


subject: CHEBI:9448

object_name: tinea corporis


subject: CHEBI:9448


subject: CHEBI:9448


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: heart failure

tested_intervention: yes


subject: UMLS:C0085297

object_name: Heart Failure, CTCAE


subject: CHEBI:466659

object_name: plasma cell myeloma


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Fall, CTCAE


subject: UMLS:C0770246

object_name: Falls


subject: UMLS:C4055105

subject_name: EGFR Antibody

object_name: colorectal cancer


subject: UMLS:C4055105

object_name: colorectal carcinoma


subject: UMLS:C4055105

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4055105

object_name: cholangiocarcinoma


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine


subject: UMLS:C4760648


subject: CHEBI:15940

subject_name: Niacin

object_name: Flushing


subject: CHEBI:15940

object_name: Flushing, CTCAE 5.0


subject: CHEBI:15940

object_name: Flushing, CTCAE 3.0


subject: CHEBI:15940

object_name: Erythema


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: celiac disease


subject: UMLS:C5238480

object_name: prostate neoplasm


subject: UMLS:C0771364

subject_name: Echinacea angustifolia extract

object_name: generalized anxiety disorder


subject: CHEMBL.COMPOUND:CHEMBL2109053

subject_name: ECHINACEA ANGUSTIFOLIA


subject: UNII:J43DL56H6M

subject_name: foralumab


subject: UNII:J43DL56H6M

object_name: COVID-19 respiratory infection


subject: UMLS:C2987422


subject: UMLS:C2987422


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Relapsing classical Hodgkin lymphoma


subject: DRUGBANK:DB17743

subject_name: Fecal microbiota

object_name: ulcerative colitis


subject: DRUGBANK:DB17743

object_name: inflammatory bowel disease 1


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: acute leukemia


subject: CHEBI:85361

subject_name: tetramethylsilane


subject: CHEBI:85361

object_name: Hodgkin Disease


subject: CHEBI:85361

object_name: Myelodysplasia


subject: CHEBI:85361

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:85361

object_name: childhood myelodysplastic syndrome


subject: CHEBI:85361

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:85361

object_name: plasma cell myeloma


subject: MESH:C029401

subject_name: Ensure Plus

object_name: bladder tumor


subject: MESH:C029401

object_name: urinary bladder carcinoma


subject: MESH:C029401

object_name: urinary bladder cancer


subject: MESH:C029401

object_name: childhood bladder carcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Bone Mineral Density


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:28061

subject_name: galactose

object_name: hyperlipidemia


subject: CHEBI:28061

object_name: Lipidemias


subject: CHEBI:28061

object_name: Heart Disease Risk Factors


subject: CHEBI:42905

subject_name: L-Galactose


subject: CHEBI:42905


subject: CHEBI:42905


subject: KEGG.COMPOUND:C01582

subject_name: Galactose


subject: KEGG.COMPOUND:C01582


subject: KEGG.COMPOUND:C01582


subject: PUBCHEM.COMPOUND:2269

object_name: Graft Rejection


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:2269

object_name: Trichiasis


subject: UMLS:C0812732


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Hepatic impairment


subject: CHEBI:75929

object_name: Childhood Breast Carcinoma


subject: CHEBI:75929

object_name: breast carcinoma


subject: CHEBI:75929

object_name: breast cancer


subject: CHEBI:75929

object_name: neurotoxicity


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:40009


subject: CHEBI:40009


subject: CHEBI:33322

subject_name: Rubidium

object_name: mantle cell lymphoma


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: papillary serous cystadenocarcinoma


subject: UNII:98DE7VN88D

object_name: peritoneal carcinoma


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: urinary system neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C1655276

subject_name: T-KI


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Ocular histoplasmosis syndrome


subject: UMLS:C4722734

subject_name: ESC-GalNAc-siRNA Conjugate ALN-AS1

object_name: acute intermittent porphyria


subject: CHEBI:73508

subject_name: Glu-Pro

object_name: small cell lung carcinoma


subject: PR:000006295

subject_name: acyl-CoA-binding protein


subject: PR:000008736

subject_name: BLOC-3 complex member HPS1


subject: UMLS:C4054273

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: hematologic disorder


subject: UNII:KXQ762CQTH

object_name: Advanced Fibrolamellar Carcinoma


subject: UNII:KXQ762CQTH

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: CHEBI:68534

subject_name: Enzalutamide


subject: UNII:S4L4MM20B6


subject: UMLS:C0021031

subject_name: Fab Immunoglobulins

object_name: preeclampsia


subject: UMLS:C4722545

object_name: diabetic neuropathy


subject: CHEBI:95067

subject_name: Iniparib

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]

object_name: leukemia


subject: UMLS:C5552625

object_name: childhood leukemia


subject: MESH:C040617

subject_name: mesoglycan

object_name: abdominal obesity-metabolic syndrome


subject: MESH:C040617

object_name: metabolic syndrome X


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Shivering


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: Malignant neoplasm of colon stage IV


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C2984020

object_name: Post-polycythemia vera myelofibrosis


subject: UMLS:C2984020

object_name: Myelofibrosis due to another disorder


subject: UMLS:C2984020

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:6536850

object_name: glaucomatocyclitic crisis


subject: UMLS:C0729218


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:1W10Q5H7WD

subject_name: Giripladib

object_name: osteoarthritis


subject: CHEBI:66910

subject_name: Axitinib

object_name: lung neoplasm


subject: UMLS:C5418072

subject_name: Anti-CD47 Monoclonal Antibody IMC-002

object_name: EXCESS LMW-DNA


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: colorectal carcinoma


subject: CHEBI:3215

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3215

object_name: digestive system disorder


subject: CHEBI:3215

object_name: inflammatory bowel disease


subject: CHEBI:3215

object_name: gastrointestinal disease


subject: CHEBI:3215

object_name: digestive system cancer


subject: CHEBI:3215

object_name: intestinal disorder


subject: CHEBI:3215

object_name: inflammatory bowel disease 1


subject: CHEBI:3215

object_name: Crohn disease


subject: CHEBI:28918

subject_name: Epinephrine

object_name: colorectal cancer


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918

object_name: neuralgia


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: CHEBI:3756

subject_name: Clonazepam

object_name: social phobia


subject: CHEBI:9943

subject_name: Venlafaxine


subject: UMLS:C5783935

subject_name: Hpk1 Inhibitor PF-07265028

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5783935

object_name: Gastroesophageal junction cancer


subject: UMLS:C5783935

object_name: non-small cell lung carcinoma


subject: UMLS:C5783935

object_name: Stomach cancer


subject: UMLS:C5783935

object_name: gastric cancer


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C0003442

object_name: myeloid sarcoma


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UNII:4FR53SIF3A

object_name: adult acute myeloid leukemia


subject: UNII:4FR53SIF3A

object_name: childhood acute myeloid leukemia


subject: UNII:4FR53SIF3A

object_name: acute myeloid leukemia


subject: UNII:4FR53SIF3A

object_name: juvenile myelomonocytic leukemia


subject: UNII:4FR53SIF3A

object_name: Myelodysplasia


subject: UNII:4FR53SIF3A


subject: HMDB:HMDB0032337

subject_name: Hydroxypropyl cellulose

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337

object_name: acute lymphoblastic leukemia


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: HMDB:HMDB0032337


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:31348

subject_name: Capecitabine

object_name: appendix carcinoma


subject: CHEBI:31348

object_name: metastatic neoplasm


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990

object_name: small intestine adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9

object_name: Metastatic Lesion


subject: UNII:B2K5L1L8S9


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: pterygium


subject: CHEBI:194095

object_name: conjunctival pterygium


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: UNII:QZ8ETV7QYU

object_name: progressive myoclonus epilepsy


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Dysphagia


subject: UNII:M487QF2F4V

object_name: Dysphagia, CTCAE


subject: UNII:M487QF2F4V

object_name: mucositis


subject: UNII:M487QF2F4V

object_name: Xerostomia


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Metastatic Colorectal Adenocarcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Recurrent ovarian cancer


subject: CHEBI:42588

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:42588

object_name: Ovarian cancer stage IV


subject: CHEBI:42588

object_name: recurrent primary peritoneal cavity cancer


subject: CHEBI:42588

object_name: stage IV primary peritoneal cavity cancer


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Carbon Monoxide Poisoning


subject: UNII:ON5S6N53JS

subject_name: EVENAMIDE

object_name: schizophrenia


subject: DRUGBANK:DB18775

subject_name: Evenamide


subject: UMLS:C5907958

subject_name: BCR-ABL Inhibitor TGRX-678

object_name: leukemia, myeloid, accelerated-phase


subject: CHEMBL.COMPOUND:CHEMBL4298205

subject_name: ETIGILIMAB

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298205

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298205

object_name: Adult Solid Neoplasm


subject: UMLS:C4684842

subject_name: Etigilimab


subject: UMLS:C4684842


subject: UMLS:C4684842


subject: UMLS:C2830036

object_name: Carcinoma breast stage IV


subject: UMLS:C0912413

subject_name: PTK 787

object_name: malignant soft tissue neoplasm


subject: UMLS:C0912413

object_name: sarcoma


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: CHEMBL.COMPOUND:CHEMBL3707316

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:74088

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:74088

object_name: Embolism, Tumor


subject: CHEBI:74088

object_name: Neoplasm Metastasis


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:73805


subject: CHEBI:73805


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UNII:768FW21J3L


subject: UNII:768FW21J3L


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: UNII:CJN36EQM0H


subject: UNII:CJN36EQM0H


subject: UMLS:C1519228

subject_name: Selective Estrogen Receptor Down Regulator


subject: UMLS:C1519228


subject: UMLS:C1519228


subject: UMLS:C4085979


subject: UMLS:C5555006

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555006

object_name: breast carcinoma


subject: UMLS:C5555006

object_name: breast cancer


subject: UMLS:C5555006


subject: UMLS:C5555006


subject: UMLS:C5555006


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554


subject: UMLS:C5203926


subject: UMLS:C5203926


subject: UMLS:C5203926


subject: UMLS:C5203926


subject: UMLS:C5203926


subject: UMLS:C5239418


subject: UMLS:C5239418


subject: UMLS:C5239418


subject: UMLS:C5239418


subject: UMLS:C5239418


subject: UMLS:C5239418


subject: UNII:70FJN2AW22


subject: UNII:70FJN2AW22


subject: UNII:70FJN2AW22


subject: UNII:70FJN2AW22


subject: UNII:70FJN2AW22


subject: UNII:70FJN2AW22


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C4287708


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390


subject: UMLS:C4287707


subject: UMLS:C4287707


subject: UMLS:C4725919

subject_name: MEK Inhibitor SHR 7390


subject: UMLS:C4725919


subject: UMLS:C4725919


subject: UMLS:C4725919


subject: UMLS:C4725919


subject: UMLS:C4725919


subject: GTOPDB:1160

subject_name: hCG

object_name: hypogonadotropic hypogonadism 7 with or without anosmia


subject: UNII:8S5OIN36X4

subject_name: Seviteronel


subject: UNII:8S5OIN36X4


subject: UNII:8S5OIN36X4


subject: UNII:8S5OIN36X4

object_name: Advanced breast cancer


subject: UNII:8S5OIN36X4

object_name: estrogen-receptor positive breast cancer


subject: UNII:8S5OIN36X4

object_name: male breast carcinoma


subject: UNII:8S5OIN36X4


subject: UNII:8S5OIN36X4

object_name: triple-negative breast carcinoma


subject: UNII:8S5OIN36X4

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:J0FI6WE1QN

subject_name: Casirivimab

object_name: Immunocompromised Host


subject: UNII:2Z3DQD2JHM

subject_name: Imdevimab


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: end stage renal failure


subject: CHEBI:73788

object_name: Chronic uremia


subject: UMLS:C0594563

subject_name: Dipeptiven


subject: UMLS:C0594563


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: Complications of bone marrow transplant


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: primary intestinal lymphangiectasia


subject: UNII:A3ULP0F556

object_name: protein-losing enteropathy


subject: UNII:A3ULP0F556

object_name: Complement regulatory factor defect


subject: UNII:A3ULP0F556

object_name: Decay accelerating factor deficiency


subject: CHEBI:567361

subject_name: Cladribine

object_name: systemic mastocytosis


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: schizophrenia


subject: CHEBI:4653

object_name: schizophreniform disorder


subject: CHEBI:4653

object_name: schizoaffective disorder


subject: CHEBI:4653

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:86821

object_name: Heart Disease Risk Factors


subject: CHEBI:26125

subject_name: phytosterols


subject: PUBCHEM.COMPOUND:56841860

subject_name: Tenofovir exalidex

object_name: kidney failure


subject: CHEBI:4672

subject_name: Docetaxel


subject: RXCUI:2122515

subject_name: dolutegravir / lamivudine Oral Product

object_name: HIV infection


subject: CHEBI:8871

subject_name: Risperidone

object_name: Abnormality of extrapyramidal motor function


subject: CHEBI:94534

subject_name: olanzapine


subject: UMLS:C0728960

subject_name: Analgesic brand of acetaminophen-phenyltoloxamine

object_name: non-Hodgkin lymphoma


subject: CHEBI:35480

subject_name: analgesic


subject: CHEBI:35493

subject_name: antipyretic


subject: UMLS:C0003419

subject_name: Antipyretics


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Carotid Artery Plaque


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: Diabetic foot ulcer


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: CHEBI:17632

subject_name: Nitrate


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Postoperative delirium


subject: UNII:0K5743G68X

object_name: Emergence Delirium


subject: UNII:0K5743G68X

object_name: post-operative delirium


subject: CHEBI:135673

subject_name: Rupatadine

object_name: Atopic rhinitis


subject: CHEBI:135673

object_name: Allergic Rhinitis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4594530

subject_name: TILVESTAMAB

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4594530

object_name: ovarian neoplasm


subject: UMLS:C5446802

subject_name: Tilvestamab


subject: UMLS:C5446802


subject: UNII:W2P7EF7O6O

object_name: gram-positive bacterial infections


subject: UNII:W2P7EF7O6O

object_name: Skin and subcutaneous tissue bacterial infections


subject: DRUGBANK:DB16312


subject: DRUGBANK:DB16312


subject: UNII:ZAU91150SB

subject_name: Tefinostat

object_name: liver carcinoma


subject: UMLS:C0770687

subject_name: Varicella virus live vaccine

object_name: Shingles, CTCAE


subject: UMLS:C3464497

subject_name: varicella-zoster virus vaccine live (Oka-Merck) strain


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: multiple sclerosis


subject: CHEBI:3125

object_name: Bowel incontinence


subject: CHEBI:3125

object_name: Fecal Incontinence, CTCAE


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: nephrolithiasis


subject: CHEBI:132922

object_name: Soft Tissue Injuries


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: preeclampsia


subject: UMLS:C0082559

subject_name: Feiba

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: CHEBI:36796

subject_name: duloxetine

object_name: Biliary System Disorder


subject: CHEBI:36796

object_name: gallbladder disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: digestive system cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: type 1 diabetes mellitus


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:4672

subject_name: Docetaxel

object_name: disease free survival


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: PUBCHEM.COMPOUND:54605501

subject_name: Solu-Medrol

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:54605501

object_name: non-Hodgkin lymphoma


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: Overweight


subject: CHEBI:49325

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:49325

object_name: obesity


subject: CHEBI:49325

object_name: Obesity, CTCAE


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: UMLS:C0009905


subject: UMLS:C0009905


subject: UMLS:C0009905


subject: CHEBI:25657

subject_name: octyl group


subject: CHEBI:25657


subject: CHEBI:25657


subject: CHEBI:25657


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: Inflammation


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: arteriosclerosis disorder


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: atherosclerosis


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU


subject: UNII:9YCX42I8IU


subject: GTOPDB:12060

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666982

subject_name: CD137/Nectin-4 Bispecific-targeting Agent BT7480


subject: CHEMBL.COMPOUND:CHEMBL3833386

subject_name: GALINPEPIMUT-S

object_name: plasma cell myeloma


subject: UMLS:C5206092

subject_name: Galinpepimut-S


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: bipolar disorder


subject: UMLS:C1565135

subject_name: Ethyl-EPA


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:17026

subject_name: Progesterone

object_name: Morbidity


subject: CHEBI:17026

object_name: Perinatal death


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C0388984

object_name: diabetic kidney disease


subject: UMLS:C5782094

subject_name: XPO1 Inhibitor

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C5782094

object_name: Advanced Lymphoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: testicular germ cell tumor 1


subject: UMLS:C0919079

object_name: testicular germ cell tumor


subject: UMLS:C0919079

object_name: childhood testicular germ cell tumor


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: MESH:C000654176

object_name: Urinary Urgency


subject: MESH:C000654176

object_name: Urinary Bladder, Underactive


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Ureteral Calculi


subject: CHEBI:46195

object_name: ureterolithiasis


subject: PUBCHEM.COMPOUND:21982135


subject: PUBCHEM.COMPOUND:21982135


subject: PUBCHEM.COMPOUND:21982135

object_name: renal colic


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:73038


subject: CHEBI:73038


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Childhood Synovial Sarcoma


subject: UNII:D99YVK4L0X

object_name: Adult Synovial Sarcoma


subject: UNII:D99YVK4L0X

object_name: synovial sarcoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:80270

object_name: Diabetes


subject: CHEBI:80270

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: lung cancer


subject: CHEBI:28240

object_name: lung neoplasm


subject: CHEBI:28240

object_name: lung carcinoma


subject: CHEBI:28240

object_name: Carcinoma breast stage IV


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:36386


subject: CHEBI:36386


subject: CHEBI:36386


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: BCR-ABL1 Fusion Protein Expression


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UMLS:C0876889

subject_name: Pediatric brand name

object_name: tinea cruris


subject: UMLS:C0876889

object_name: tinea pedis


subject: CHEBI:149504

object_name: Scar formation


subject: CHEBI:149504

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: UNII:T12B44A1OE

subject_name: Acoramidis

object_name: hereditary amyloidosis


subject: UMLS:C5400804

subject_name: TTR Stabilizer AG10

object_name: cardiomyopathy


subject: UMLS:C5400804

object_name: polyneuropathy


subject: UMLS:C5400804

object_name: amyloidosis


subject: UMLS:C5400804

object_name: amyloidosis, hereditary systemic 1


subject: UMLS:C5400804

object_name: familial amyloid neuropathy


subject: UMLS:C5400804


subject: UMLS:C5400804

object_name: heart disorder


subject: UMLS:C0534628

subject_name: Endostatins

object_name: melanoma


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:16335

subject_name: Adenosine

object_name: Acute Respiratory Distress


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: esophageal squamous cell carcinoma


subject: CHEBI:79068

subject_name: Crocin

object_name: Stress


subject: CHEBI:79068

object_name: insomnia


subject: CHEBI:79068

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:79068

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C3696061

subject_name: saffron extract


subject: UMLS:C3696061


subject: UMLS:C3696061


subject: UMLS:C3696061


subject: UMLS:C0162753

subject_name: saffron stain


subject: UMLS:C0162753


subject: UMLS:C0162753


subject: UMLS:C0162753


subject: UMLS:C5227010

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Intraventricular hemorrhage of prematurity


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Recurrent Uterine Sarcoma


subject: UNII:15C2VL427D

object_name: ovarian sarcoma


subject: UNII:15C2VL427D

object_name: Stage III Uterine Sarcoma AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: UNII:15C2VL427D

object_name: leiomyosarcoma of the corpus uteri


subject: UNII:15C2VL427D

object_name: ovarian carcinosarcoma


subject: UNII:15C2VL427D

object_name: carcinosarcoma of the corpus uteri


subject: UNII:15C2VL427D

object_name: uterine carcinosarcoma


subject: UNII:15C2VL427D

object_name: Ovarian cancer stage III


subject: UNII:15C2VL427D

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:15C2VL427D

object_name: Ovarian cancer stage IV


subject: UNII:15C2VL427D

object_name: female reproductive organ cancer


subject: RXCUI:605343

subject_name: Synera

object_name: Encounter due to palliative care


subject: RXCUI:605343

object_name: diagnostic service sources phlebotomy


subject: CHEBI:9468

subject_name: Tetracaine


subject: CHEBI:9468


subject: CHEBI:74698

subject_name: Met-Arg

object_name: Brain Lesion


subject: CHEBI:74698

object_name: metastatic malignant neoplasm in the brain


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: PR:000011407


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Myocardial Reperfusion Injury


subject: CHEBI:2668

subject_name: Amlodipine

object_name: myocardial ischemia


subject: CHEBI:2668

object_name: Family history of ischemic heart disease


subject: UMLS:C4053669

object_name: Hormone-dependent prostate cancer


subject: UMLS:C5418077

subject_name: Anti-c-Met Monoclonal Antibody HLX55

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C2348337


subject: UMLS:C2697511

object_name: HIV infection


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Postoperative Pain, Acute


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: CHEBI:4670

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: CHEBI:4670

object_name: Left ventricular systolic dysfunction


subject: CHEBI:4670

object_name: cardiomyopathy


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic Breast Carcinoma


subject: UNII:6QVL057INT

object_name: Metastatic carcinoma to liver


subject: UNII:6QVL057INT

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Stage 3 chronic kidney disease


subject: UMLS:C2984025

object_name: Stage 4 chronic kidney disease


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: pleural mesothelioma


subject: UNII:QEN1X95CIX

object_name: malignant pleural mesothelioma


subject: UNII:QEN1X95CIX

object_name: peritoneal mesothelioma


subject: UNII:QEN1X95CIX

object_name: malignant peritoneal mesothelioma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:67RM91WDHQ

subject_name: Onvansertib

object_name: Carcinoma breast stage IV


subject: UNII:67RM91WDHQ

object_name: Childhood Breast Carcinoma


subject: UNII:67RM91WDHQ

object_name: breast carcinoma


subject: UNII:67RM91WDHQ

object_name: breast cancer


subject: UNII:67RM91WDHQ

object_name: Her2-receptor negative breast cancer


subject: UNII:67RM91WDHQ

object_name: invasive breast carcinoma


subject: UNII:67RM91WDHQ

object_name: inflammatory breast carcinoma


subject: UNII:67RM91WDHQ

object_name: Locally advanced breast cancer


subject: UNII:67RM91WDHQ

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UNII:67RM91WDHQ

object_name: hormone receptor/growth factor receptor-negative breast cancer


subject: UNII:67RM91WDHQ

object_name: Unresectable Breast Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C3530191

object_name: cocaine abuse


subject: CHEBI:5390

subject_name: Glu-Glu

object_name: myocardial ischemia


subject: CHEBI:5390

object_name: coronary atherosclerosis


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:9150

subject_name: Simvastatin

object_name: HIV infection


subject: UMLS:C4725098

subject_name: HAAH Lambda phage Vaccine SNS-301

object_name: prostate carcinoma


subject: UMLS:C4725098

object_name: prostate cancer


subject: CHEBI:230905

subject_name: Ribociclib

object_name: adult lymphoma


subject: CHEBI:230905

object_name: lymphoma


subject: CHEBI:230905

object_name: pediatric lymphoma


subject: CHEBI:230905

object_name: Solid Neoplasm


subject: UMLS:C1948065

subject_name: ZIO 201

object_name: Advanced Sarcoma


subject: UMLS:C1384659

object_name: Childhood Neuroblastoma


subject: UMLS:C1384659

object_name: neuroblastoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: UNII:FA9BPX1T6V

subject_name: Epeleuton

object_name: sickle cell disease


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:49005

object_name: myoclonic dystonia 11


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Myelodysplasia


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:A6KAB92LQ7

object_name: cystic fibrosis


subject: UMLS:C5706523

subject_name: Anti-Claudin-18.2 Monoclonal Antibody SPX-101


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Failed conscious sedation during procedure


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Severe depressive episode without psychotic symptoms


subject: CHEBI:9123

subject_name: Sertraline


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: osteoarthritis, hip


subject: UNII:9566855ULN

object_name: osteoarthritis, knee


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:6759


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: fibrolamellar hepatocellular carcinoma


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:3764

subject_name: Clotrimazole

object_name: folliculitis


subject: CHEBI:3764

object_name: Folliculitis, CTCAE


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion


subject: PUBCHEM.COMPOUND:2307


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:90620

subject_name: Vatalanib

object_name: neoplasm


subject: UMLS:C0912413

subject_name: PTK 787


subject: CHEBI:90623


subject: CHEBI:90623

object_name: Neoplasm Metastasis


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: UMLS:C0247947

subject_name: exendin (9-39)

object_name: morbid obesity


subject: UMLS:C0247947

object_name: Class 3 Obesity


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: UMLS:C1831904

subject_name: ThermoDox

object_name: non-small cell lung carcinoma


subject: UMLS:C1831904

object_name: small cell lung carcinoma


subject: UMLS:C1831904

object_name: esophageal adenocarcinoma


subject: UMLS:C1831904

object_name: lung adenocarcinoma


subject: UMLS:C1831904

object_name: cervical adenocarcinoma


subject: UMLS:C1831904

object_name: adenocarcinoma


subject: UMLS:C1831904

object_name: bile duct adenocarcinoma


subject: UMLS:C1831904

object_name: gastric adenocarcinoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: DRUGBANK:DB17293

object_name: Ovarian cancer stage IV


subject: DRUGBANK:DB17293

object_name: malignant neoplasm of ovary stage IV


subject: DRUGBANK:DB17293

object_name: Recurrent ovarian cancer


subject: DRUGBANK:DB17293

object_name: Ovarian cancer stage III


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: membranous glomerulonephritis


subject: CHEBI:6375

object_name: nephrotic syndrome


subject: CHEBI:6375

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:6375

object_name: glomerulonephritis


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: UMLS:C4078792

object_name: asthma


subject: UMLS:C5395912

subject_name: Vaccine product containing only Bacillus anthracis antigen (medicinal product)

object_name: anthrax disease


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: neoplastic meningitis


subject: UMLS:C3641122


subject: UNII:28X28X9OKV

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C3641122


subject: DRUGBANK:DB05821

subject_name: DP-VPA

object_name: migraine


subject: DRUGBANK:DB05821

object_name: migraine with or without aura, susceptibility to, 1


subject: DRUGBANK:DB14179

subject_name: Phleum pratense top

object_name: Allergy


subject: DRUGBANK:DB14179

object_name: History of allergies


subject: UMLS:C1446714

subject_name: Phleum pratense allergenic extract


subject: UMLS:C1446714


subject: DRUGBANK:DB10394

subject_name: Phleum pratense pollen


subject: DRUGBANK:DB10394


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Ventral hernia


subject: CHEBI:46195

object_name: stomach disease


subject: CHEBI:46195

object_name: intestinal disorder


subject: UNII:DE4G8X55F5

subject_name: Aticaprant

object_name: Anhedonia


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Sensory hearing loss


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Physical trauma


subject: CHEBI:64356

object_name: Injury


subject: CHEBI:64356

object_name: Trauma


subject: CHEBI:64356

object_name: urologic injuries


subject: CHEBI:64356

object_name: Male Genital Injuries


subject: CHEBI:64356

object_name: Female genital injuries


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Ann Arbor Stage II Grade 1 Follicular Lymphoma


subject: CHEBI:63791

object_name: Ann Arbor Stage II Grade 2 Follicular Lymphoma


subject: CHEBI:63791

object_name: Bulky Disease


subject: CHEBI:63791

object_name: Splenomegaly


subject: CHEBI:63791

object_name: Weight loss


subject: CHEBI:63791

object_name: Weight Loss, CTCAE


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Night sweats


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Fatigue, CTCAE 5.0


subject: UNII:O43472U9X8

object_name: Fatigue


subject: UNII:O43472U9X8

object_name: Fever


subject: UNII:O43472U9X8

object_name: Fever symptoms (finding)


subject: UNII:O43472U9X8

object_name: Fever, CTCAE


subject: CHEBI:15891

subject_name: Taurine

object_name: Insulin resistance


subject: DRUGBANK:DB16530

subject_name: Dialyzable leukocyte extract


subject: CHEBI:229658

subject_name: Perfluorohexyloctane

object_name: Evaporative Dry Eye Disease


subject: CHEBI:229658

object_name: xerophthalmia


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:23279496

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:23279496

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:23279496

object_name: psychosis


subject: CHEBI:6129

subject_name: Ketorolac

object_name: pancreatitis


subject: CHEBI:6129

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:6129

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:391960

subject_name: Darifenacin

object_name: multiple sclerosis


subject: CHEBI:391960

object_name: Overactive Detrusor


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: type 2 diabetes mellitus


subject: CHEBI:146176

subject_name: levomethorphan


subject: UMLS:C1815270

subject_name: Biostate

object_name: hemophilia A


subject: CHEMBL.COMPOUND:CHEMBL5314657

subject_name: BEMDANEPROCEL

object_name: Parkinson disease


subject: UMLS:C2985193

subject_name: Monofer

object_name: inflammatory bowel disease


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Anticoagulants and Bleeding Disorders


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: UMLS:C3641943

subject_name: Cathepsin-Activatable Cy5 Fluorescent Imaging Probe LUM015

object_name: Childhood Breast Carcinoma


subject: UMLS:C3641943

object_name: breast carcinoma


subject: UMLS:C3641943

object_name: breast cancer


subject: UMLS:C3641943

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C3641943

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C3641943

object_name: sarcoma


subject: UMLS:C3641943

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C3641943

object_name: soft tissue sarcoma


subject: UMLS:C3641943

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:2735

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:2735

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C1658729

subject_name: CERAVE

object_name: acne


subject: UNII:6897GXD6OE

object_name: kidney failure


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution


subject: CHEBI:28915

subject_name: Fosfomycin


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Melanoma and other malignant neoplasms of skin (C43-C44)


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C5205928

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB


subject: UMLS:C4527193


subject: PUBCHEM.COMPOUND:9837966

subject_name: Radafaxine

object_name: major depressive disorder


subject: CHEMBL.COMPOUND:CHEMBL2108994

subject_name: CARAWAY OIL

object_name: irritable bowel syndrome


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Pregnancy Outcome


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: gastroesophageal cancer


subject: CHEBI:5062

subject_name: Finasteride

object_name: Hematospermia


subject: CHEBI:5062

object_name: Hematuria, CTCAE


subject: CHEBI:5062

object_name: Hematuria


subject: CHEBI:45716

subject_name: Vorinostat

object_name: hormone-resistant prostate carcinoma


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: premenstrual tension


subject: DRUGBANK:DB16615

object_name: polydactyly-myopia syndrome


subject: CHEBI:6015

subject_name: Isoflurane

object_name: heart disorder


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: cutis laxa


subject: UNII:9P1872D4OL

subject_name: Exenatide

object_name: Diabetes


subject: MESH:C533794

object_name: Metastatic malignant neoplasm to liver


subject: MESH:C533794

object_name: neoplasm


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: carpal tunnel syndrome 1


subject: CHEBI:89324

object_name: carpal tunnel syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:8382

subject_name: Prednisone

object_name: type IV hypersensitivity disease


subject: CHEBI:83766

subject_name: Olaparib

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:83766

object_name: Squamous cell carcinoma of head and neck recurrent


subject: PUBCHEM.COMPOUND:9551858

subject_name: CETIRIZINE HYDROCHLORIDE

object_name: Prostatitis category III (National Institute of Health classification)


subject: CHEBI:3561

subject_name: Cetirizine


subject: CHEBI:59773

subject_name: CROMOLYN


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: chronic hepatitis B virus infection


subject: UMLS:C3714803

object_name: hepatitis B


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Fatty Liver


subject: CHEBI:473990

subject_name: Entecavir


subject: UMLS:C0116580

subject_name: Essentiale


subject: UMLS:C0116580


subject: UMLS:C0116580


subject: UNII:6MC966B505

object_name: Solid Neoplasm


subject: UNII:6MC966B505

object_name: Refractory acute myeloid leukemia


subject: UNII:6MC966B505

object_name: Relapsing acute myeloid leukemia


subject: UNII:6MC966B505

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL4594474


subject: CHEMBL.COMPOUND:CHEMBL4594474


subject: CHEMBL.COMPOUND:CHEMBL4594474


subject: CHEMBL.COMPOUND:CHEMBL4594474


subject: UMLS:C5706441

subject_name: Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049

object_name: lung cancer


subject: UMLS:C5706441

object_name: lung neoplasm


subject: UMLS:C5706441

object_name: lung carcinoma


subject: UMLS:C5706441

object_name: liver cancer


subject: UMLS:C5706441

object_name: liver neoplasm


subject: UMLS:C5706441

object_name: Adult Liver Carcinoma


subject: UMLS:C5706441

object_name: liver carcinoma


subject: UMLS:C5706441

object_name: Neck Carcinoma


subject: UMLS:C5706441

object_name: head and neck neoplasm


subject: UMLS:C5706441

object_name: head and neck cancer


subject: UMLS:C5706441

object_name: pancreatic neoplasm


subject: UMLS:C5706441

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706441

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706441

object_name: colorectal cancer


subject: UMLS:C5706441

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5706441

object_name: digestive system cancer


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UNII:5V1UI86573


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329334


subject: UMLS:C4329336

object_name: childhood neoplasm


subject: UMLS:C4329336

object_name: neoplastic syndrome


subject: UMLS:C4329336

object_name: cancer or benign tumor


subject: UMLS:C0356365

subject_name: Insulin, Short-Acting

object_name: Neuropathic corneal ulcer


subject: UMLS:C0356365

object_name: corneal ulcer


subject: UMLS:C0356365

object_name: Corneal Ulcer, CTCAE


subject: UNII:69VJ1LPN1S

subject_name: hempseed oil

object_name: Frontal balding


subject: UMLS:C5383290

subject_name: hyaluronidase-fihj

object_name: Plasma cell myeloma refractory


subject: UMLS:C5383290

object_name: Plasma cell myeloma recurrent


subject: CHEBI:85991

subject_name: panobinostat lactate


subject: CHEBI:85991


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:92043599

object_name: head and neck cancer


subject: UMLS:C4086207

object_name: Pregnant


subject: UMLS:C0357807

subject_name: Benzydamine hydrochloride 0.15% oral rinse

object_name: Effects of radiation


subject: UMLS:C0357807

object_name: stomatitis


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: traumatic encephalopathy


subject: UNII:5QS67N4551

object_name: traumatic brain injury


subject: UNII:5QS67N4551

object_name: Head Injury


subject: UMLS:C2366367

subject_name: Cinryze


subject: UMLS:C2366367


subject: UMLS:C2366367


subject: CHEBI:44915

subject_name: Propofol

object_name: Tethered cord


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: Mammographic Breast Density


subject: PUBCHEM.COMPOUND:3962

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Blastoid Variant Mantle Cell Lymphoma


subject: CHEBI:4026

object_name: Pleomorphic Variant Mantle Cell Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: mantle cell lymphoma


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: glucose intolerance


subject: CHEBI:4466

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:4466

object_name: Insulin resistance


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:S7H48S6K7H

subject_name: Troriluzole

object_name: Alzheimer disease type 1


subject: UNII:S7H48S6K7H

object_name: Alzheimer disease


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: anemia


subject: UNII:Q46947FE7K

object_name: Anemia, CTCAE


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Heart failure NYHA class IV


subject: PUBCHEM.COMPOUND:54214995

object_name: Heart failure NYHA class II


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: nephrotic syndrome


subject: CHEBI:7986

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: prostate carcinoma


subject: CHEBI:7915

object_name: prostate cancer


subject: UMLS:C2744441

object_name: neoplasm


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Weaning failure


subject: UNII:349552KRHK

object_name: Muscle weakness conditions


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: otitis media


subject: PUBCHEM.COMPOUND:70789201

object_name: infectious otitis media


subject: PUBCHEM.COMPOUND:70789201

object_name: Otitis Media, CTCAE


subject: UMLS:C0663674


subject: UMLS:C0663674


subject: UMLS:C0663674


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:52717

subject_name: Bortezomib

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:52717

object_name: Stage II Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Stage II Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:8207

subject_name: Pilocarpine

object_name: Vaginal Dryness, CTCAE 5.0


subject: CHEBI:8207

object_name: Vaginal Dryness, CTCAE 3.0


subject: CHEBI:8207

object_name: Vaginal dryness


subject: CHEBI:8207

object_name: Childhood Breast Carcinoma


subject: CHEBI:8207

object_name: breast carcinoma


subject: CHEBI:8207

object_name: breast cancer


subject: CHEBI:177298

object_name: endometrial cancer


subject: CHEBI:177298

object_name: uterine corpus cancer


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:4856

subject_name: Esmolol

object_name: Esmolol adverse reaction


subject: CHEBI:32599


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Thoracic Diseases


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C5854549

subject_name: Anti-4-1BB/5T4 Bispecific Antibody ALG.APV-527

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854549

object_name: Adult Solid Neoplasm


subject: UMLS:C5854549

object_name: Solid Neoplasm


subject: UMLS:C4085936

object_name: non-small cell lung carcinoma


subject: CHEBI:229722

subject_name: camonsertib


subject: UNII:S1Z7Y5G56T

subject_name: CAMONSERTIB


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab


subject: CHEBI:95089

subject_name: Ipatasertib


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin


subject: UMLS:C3896776

subject_name: cibisatamab


subject: UMLS:C5205927


subject: CHEBI:71940

subject_name: Tadalafil

object_name: interstitial lung disease


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: Subfertility


subject: PR:000007971

subject_name: somatoliberin


subject: UMLS:C2987382

subject_name: Antrodia cinnamomea Supplement

object_name: lung cancer


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab

object_name: Reperfusion Injury


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: masticatory muscles, hypertrophy of


subject: UMLS:C0086333

subject_name: Gammagard

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: diastolic heart failure


subject: CHEBI:31547

subject_name: Eplerenone


subject: UMLS:C5570977

subject_name: 2.5% Dextrose

object_name: trauma to the abdomen


subject: UMLS:C5570977

object_name: Acute abdomen


subject: UMLS:C5570977

object_name: Surgical wound


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Nausea and vomiting


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:15640

subject_name: Leucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: colorectal cancer


subject: UNII:YZS3R7LP44

object_name: colorectal carcinoma


subject: UNII:YZS3R7LP44

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:4305

subject_name: dacarbazine

object_name: uveal melanoma


subject: CHEBI:4305

object_name: iris melanoma


subject: CHEBI:4305

object_name: small size posterior uveal melanoma


subject: CHEBI:4305

object_name: medium/large size posterior uveal melanoma


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C0021735

object_name: Recurrent Uveal Melanoma


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:Q46947FE7K

object_name: Neoplasm of uncertain behavior


subject: CHEBI:3757

subject_name: Clonidine

object_name: Psychedelic Experiences


subject: UMLS:C0718116

subject_name: vitamin A and D topical

object_name: Female pattern alopecia (disorder)


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: type 2 diabetes mellitus


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: UMLS:C0718340

subject_name: Alesse

object_name: acromegaly


subject: UMLS:C0718340

object_name: Acral overgrowth


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: Calcification


subject: CHEBI:48390

object_name: calcinosis


subject: CHEBI:48390

object_name: Vascular calcification


subject: CHEBI:48390

object_name: cardiovascular disorder


subject: CHEBI:48390

object_name: Coronary artery calcification


subject: UMLS:C5555004

subject_name: Izalontamab

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Prostate cancer recurrent


subject: UMLS:C0971731


subject: UMLS:C1831996

subject_name: DTA-H19 Plasmid

object_name: bladder tumor


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: bone marrow failure syndrome


subject: UNII:3A189DH42V

object_name: Immunodeficiency congenital


subject: UNII:3A189DH42V

object_name: myeloid neoplasm


subject: UNII:3A189DH42V

object_name: metabolic disease


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:18459832

subject_name: Finafloxacin

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:18459832

object_name: Recurrent urinary tract infections


subject: UMLS:C4329594

subject_name: CEA-MUC-1-TRICOM Vaccine CV301

object_name: colorectal carcinoma


subject: UMLS:C4086994


subject: UMLS:C3273725


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Chemotherapy-induced nausea and vomiting


subject: PUBCHEM.COMPOUND:230076

subject_name: Aureolic acid

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:230076

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:230076

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:230076

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:230076

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:230076

object_name: breast cancer


subject: PUBCHEM.COMPOUND:230076

object_name: lung cancer


subject: PUBCHEM.COMPOUND:230076

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:230076

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:230076

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:31856

subject_name: Plicamycin


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: UNII:8WE94VAO6U

subject_name: chiglitazar

object_name: Hepatic impairment


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C0935953

subject_name: Mobist


subject: UMLS:C5235866

subject_name: DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151


subject: UMLS:C4309517


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: GTOPDB:9517

subject_name: atacicept

object_name: optic neuritis


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: UMLS:C2351058

subject_name: Atacicept


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: glioma susceptibility 1


subject: UMLS:C0599934

object_name: adult oligodendroglioma


subject: UMLS:C0599934

object_name: oligodendroglioma


subject: UMLS:C0599934

object_name: childhood oligodendroglioma


subject: UMLS:C0599934

object_name: Childhood Oligoastrocytoma


subject: UMLS:C0599934

object_name: oligoastrocytoma


subject: UMLS:C0599934

object_name: Childhood Astrocytoma


subject: UMLS:C0599934

object_name: astrocytic tumor


subject: UMLS:C0599934

object_name: astrocytoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: GTOPDB:10140

subject_name: spartalizumab

object_name: Metastatic malignant neoplasm to pancreas


subject: GTOPDB:10140

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:90865

subject_name: Flibanserin

object_name: Decreased libido


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Myocardial Reperfusion Injury


subject: DRUGBANK:DB10543

subject_name: Cow milk

object_name: pregnancy related


subject: DRUGBANK:DB10543

object_name: Iodine deficiency


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: brain cancer


subject: CHEBI:49900

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: skin disorder


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C1959472

object_name: bacterial conjunctivitis


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:78538

object_name: amyloidosis, hereditary systemic 1


subject: CHEBI:78538

object_name: ATTR Amyloidosis


subject: CHEBI:78538

object_name: Cardiac amyloidosis


subject: CHEBI:177298

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:177298

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Platinum-Resistant Ovarian Carcinoma


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349

object_name: Recurrent ovarian cancer


subject: HMDB:HMDB0001349

object_name: Recurrent Fallopian Tube Carcinoma


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: PUBCHEM.COMPOUND:71301231

subject_name: Artesunate and mefloquine

object_name: Refractory drug response


subject: PUBCHEM.COMPOUND:71301231

object_name: Plasmodium falciparum malaria


subject: UMLS:C3652933

subject_name: Artesunate- and mefloquine-containing product


subject: UMLS:C3652933


subject: UNII:1C6V77QF41

object_name: Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome


subject: CHEBI:27300


subject: CHEBI:34741

subject_name: Equol

object_name: Alzheimer disease type 1


subject: CHEBI:34741

object_name: Alzheimer disease


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE

object_name: chronic pain (diagnosis)


subject: UNII:7CS0WNO31M

object_name: Chronic pain


subject: UNII:7CS0WNO31M

object_name: Pulmonary compliance


subject: CHEBI:137041


subject: CHEBI:137041


subject: CHEBI:137041


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:15854


subject: CHEBI:15854


subject: CHEBI:57986


subject: CHEBI:57986


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:50634


subject: CHEBI:50634


subject: CHEBI:50634


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:3723

subject_name: Citalopram

object_name: social phobia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: AIDS-Related Hodgkin Lymphoma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699

object_name: T-cell lymphoma recurrent


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:74947

subject_name: Thalidomide

object_name: ovarian cancer


subject: CHEBI:74947

object_name: ovarian neoplasm


subject: CHEBI:74947

object_name: ovarian carcinoma


subject: UNII:3QW12I37H1

subject_name: SUROVATAMIG

object_name: EXCESS LMW-DNA


subject: UNII:3QW12I37H1

object_name: rheumatoid arthritis


subject: UMLS:C5555141


subject: UMLS:C5555141


subject: CHEBI:231679

subject_name: ipilimumab

object_name: acute lymphoblastic leukemia


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:231598

object_name: non-Hodgkin lymphoma


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: sleep disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: malignant tumor of nasopharynx


subject: CHEBI:114785

subject_name: Erlotinib

object_name: nasopharyngeal carcinoma


subject: CHEBI:114785

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:114785


subject: UNII:69VKY8P7EA

object_name: plasma cell myeloma


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C5667085

subject_name: Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:59585

object_name: Childhood Breast Carcinoma


subject: CHEBI:59585

object_name: breast carcinoma


subject: CHEBI:59585

object_name: breast cancer


subject: UMLS:C0162357

subject_name: Clodronate


subject: UMLS:C0162357


subject: UMLS:C0162357


subject: CHEBI:110423

subject_name: Clodronic acid


subject: CHEBI:110423


subject: CHEBI:110423


subject: UMLS:C5447457

subject_name: Inixaciclib

object_name: glioma


subject: UMLS:C5447457

object_name: malignant glioma


subject: UMLS:C5447457

object_name: Metastatic Breast Carcinoma


subject: UMLS:C5447457

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C5447457

object_name: Recurrent Glioblastoma


subject: UMLS:C5447457

object_name: Advanced Breast Carcinoma


subject: UMLS:C5447457

object_name: mixed glioma


subject: UMLS:C5447457

object_name: glioblastoma


subject: UMLS:C5447457

object_name: Childhood Glioblastoma


subject: UMLS:C5447457

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:I7MVZ8HDNU

subject_name: Remibrutinib

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:8863

subject_name: Riluzole

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Untreated Childhood Pineoblastoma


subject: PUBCHEM.COMPOUND:2767

object_name: Untreated Childhood Medulloblastoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: MESH:C000718753

object_name: chronic hepatitis C virus infection


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Mechanical ventilation finding


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: NK-cell lymphoma


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: small intestine cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: small intestine carcinoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: UNII:M9ALI41OQR

object_name: neoplasm


subject: MESH:C000712209

object_name: Presenile dementia


subject: MESH:C000712209

object_name: dementia


subject: MESH:C000712209

object_name: Alzheimer disease


subject: MESH:C000712209

object_name: Parkinson disease


subject: MESH:C000712209

object_name: amyotrophic lateral sclerosis


subject: MESH:C000712209

object_name: mild neurocognitive disorder


subject: MESH:C000712209

object_name: mild cognitive impairment


subject: MESH:C000654530


subject: MESH:C000654530


subject: MESH:C000654530


subject: MESH:C000654530


subject: MESH:C000654530


subject: MESH:C000654530


subject: MESH:C000654530


subject: CHEBI:79033

subject_name: florbetaben F18


subject: CHEBI:79033


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: telangiectasis


subject: CHEBI:17925

object_name: Cutaneous telangiectasia


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether


subject: CHEBI:78770


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:2724258


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:46859


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: Accidental Falls


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: malnutrition


subject: CHEBI:17650

object_name: type 2 diabetes mellitus


subject: CHEBI:17650

object_name: Diabetes


subject: CHEBI:17650

object_name: diabetes mellitus


subject: PR:000004904

subject_name: complement C5


subject: PR:000004904


subject: PR:000004904


subject: PR:000004904


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: coronary artery disorder


subject: CHEBI:73272

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: UMLS:C0667848

subject_name: Tri-Cyclen


subject: UMLS:C0667848

object_name: Insulin resistance


subject: UMLS:C0667848

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0667848

object_name: obesity


subject: UMLS:C0667848

object_name: Obesity, CTCAE


subject: UMLS:C0667848

object_name: cardiovascular disorder


subject: UMLS:C0667848

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0667848

object_name: metabolic syndrome X


subject: CHEMBL.COMPOUND:CHEMBL5095364

subject_name: BOSEROLIMAB

object_name: small cell lung carcinoma


subject: UMLS:C4733600

subject_name: Boserolimab


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C4086713

object_name: carcinoma


subject: UMLS:C4086713

object_name: digestive system neoplasm


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:Y6BX7BL23K


subject: CHEBI:28729

subject_name: alpha-D-mannose

object_name: fetal growth restriction


subject: CHEBI:28729

object_name: Pregnant


subject: CHEBI:37684

subject_name: mannose


subject: CHEBI:37684


subject: CHEBI:4208

subject_name: D-mannopyranose


subject: CHEBI:4208


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: steroid metabolism disease


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UNII:9P1872D4OL

subject_name: Exenatide

object_name: alcohol dependence in remission


subject: CHEBI:74705

subject_name: Met-Leu

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: pituitary tumor


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: traumatic encephalopathy


subject: UMLS:C1527137

object_name: traumatic brain injury


subject: UMLS:C1527137

object_name: Critical Illness


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UMLS:C1337075

subject_name: Ortho-Cyclen

object_name: Cardiovascular Risk


subject: UMLS:C1337075

object_name: Perimenopausal disorder


subject: UMLS:C1337075

object_name: Insulin Sensitivity


subject: UMLS:C4727626

subject_name: MVA-BN-brachyury-TRICOM vaccine

object_name: prostate adenocarcinoma


subject: UMLS:C1135117

subject_name: Eloxatin

object_name: colorectal cancer


subject: UMLS:C1135117

object_name: colorectal carcinoma


subject: UMLS:C1135117

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: REM sleep behavior disorder


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Thromboembolism


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Blast Phase


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: leukemia, myeloid, accelerated-phase


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: myelofibrosis


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UNII:9X33544ILS

object_name: Acute Ischemic Stroke


subject: UNII:9X33544ILS

object_name: Ischemic stroke


subject: UNII:11G3FV7PG7

subject_name: ZONAMPANEL


subject: UNII:11G3FV7PG7


subject: UMLS:C4726991

subject_name: Zonampanel


subject: UMLS:C4726991


subject: PUBCHEM.COMPOUND:66621102

object_name: Decompensated cirrhosis of liver


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic adenoid cystic carcinoma


subject: UNII:KXG2PJ551I

object_name: Recurrent Adenoid Cystic Carcinoma


subject: UNII:KXG2PJ551I

object_name: Progressive cGVHD


subject: UNII:KXG2PJ551I

object_name: Progressive Disease


subject: UNII:KXG2PJ551I

object_name: Progressive Neoplastic Disease


subject: UNII:KXG2PJ551I

object_name: IMWG Progressive Disease


subject: UNII:KXG2PJ551I

object_name: irPD (Immune-Related Response Criteria)


subject: UNII:KXG2PJ551I

object_name: Global Progressive Disease in Viscera


subject: UNII:KXG2PJ551I

object_name: RECIL PD


subject: UNII:KXG2PJ551I

object_name: Global Progressive Disease in Skin


subject: UNII:KXG2PJ551I

object_name: Global Progressive Disease


subject: UNII:KXG2PJ551I

object_name: Global Progressive Disease in Lymph Nodes


subject: UNII:KXG2PJ551I

object_name: Global Progressive Disease in Blood


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: UMLS:C3896726

subject_name: Lung-targeted Immunomodulator QBKPN

object_name: immunodeficiency disease


subject: CHEBI:16112

subject_name: Chlorogenate

object_name: Prediabetes


subject: CHEBI:16112

object_name: glucose intolerance


subject: CHEBI:16112

object_name: Impaired glucose tolerance


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: doxorubicin induced cardiomyopathy


subject: CHEBI:39548

object_name: Cardiomyopathy secondary to doxorubicin administration


subject: PUBCHEM.COMPOUND:72455102

subject_name: Vorapaxar

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:6912

object_name: Chronic uremia


subject: CHEBI:17151


subject: CHEBI:17151


subject: UMLS:C5907918

subject_name: Anti-PD-1/Anti-VEGF Bispecific Antibody JS207

object_name: non-small cell squamous lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: rectum adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage IIA Rectal Cancer AJCC v8


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: CHEBI:6801

subject_name: Metformin

object_name: schizophreniform disorder


subject: CHEBI:6801

object_name: bipolar disorder


subject: GTOPDB:9106

object_name: colorectal cancer


subject: GTOPDB:9106

object_name: colorectal carcinoma


subject: GTOPDB:9106

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:9106

object_name: pancreatic neoplasm


subject: GTOPDB:9106

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:9106

object_name: malignant pancreatic neoplasm


subject: GTOPDB:9106

object_name: non-small cell lung carcinoma


subject: UMLS:C5667109

subject_name: PARP/TNK Inhibitor JPI-547

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Primary malignant neoplasm


subject: CHEBI:47519

object_name: childhood malignant neoplasm


subject: CHEBI:47519

object_name: Malignant obstetric neoplasm


subject: UMLS:C2981824

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C2981824

object_name: Embolism, Tumor


subject: UMLS:C2981824

object_name: Neoplasm Metastasis


subject: UMLS:C2981824

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2607419

object_name: liver failure


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Colorectal cancer recurrent


subject: UNII:W0655Y0HSJ

subject_name: Calcium DTPA

object_name: Gadolinium deposition disease


subject: UNII:G79YN26H5B


subject: CHEBI:35739

subject_name: Pentetic acid


subject: UNII:NXU65IC8PG

subject_name: pentetate zinc trisodium


subject: PUBCHEM.COMPOUND:73995022

subject_name: Casein

object_name: Android obesity


subject: PUBCHEM.COMPOUND:73995022

object_name: Abdominal obesity


subject: PUBCHEM.COMPOUND:73995022

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:73995022

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:73995022

object_name: metabolic syndrome X


subject: DRUGBANK:DB10516


subject: DRUGBANK:DB10516


subject: DRUGBANK:DB10516


subject: DRUGBANK:DB10516


subject: DRUGBANK:DB10516


subject: UMLS:C0007332

subject_name: caseins


subject: UMLS:C0007332


subject: UMLS:C0007332


subject: UMLS:C0007332


subject: UMLS:C0007332


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: neurofibromatosis 1


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:75998

subject_name: Trametinib

object_name: Thyroid cancer metastatic


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:72850

subject_name: icosadienoic acid


subject: CHEBI:17026

subject_name: Progesterone

object_name: HIV-1 infection


subject: CHEBI:18132

subject_name: phosphocholine

object_name: lymphosarcoma


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942

object_name: lymphoma, non-Hodgkin, familial


subject: GTOPDB:4942

object_name: B-cell neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: chronic pancreatitis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Gastroesophageal junction cancer


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C0251514

subject_name: Acthrel

object_name: cocaine dependence


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Community-Acquired Pneumonia


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Hair-pulling


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:73611

subject_name: Met-Gly

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:73611


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Malignant cachexia


subject: UMLS:C0018061

subject_name: Gonadotropins

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]


subject: CHEBI:41275

subject_name: Benzimidazole

object_name: alveolar echinococcosis


subject: CHEBI:36622

subject_name: benzimidazole


subject: CHEBI:22715

subject_name: benzimidazoles


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: Malignant pleural effusion


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: carcinoma


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: CHEBI:6504

object_name: Cognitive impairment


subject: CHEBI:6504

object_name: Alzheimer disease type 1


subject: CHEBI:6504

object_name: Alzheimer disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: plastic bronchitis


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Shoulder arthritis


subject: PUBCHEM.COMPOUND:152165

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:8249

subject_name: Piroxicam


subject: UNII:75G4TW236W

subject_name: Meglumine antimoniate

object_name: Chiclero ulcer


subject: CHEBI:45783

subject_name: Imatinib

object_name: nephrogenic systemic fibrosis


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Blood Pressure Finding


subject: CHEBI:22652

object_name: Systemic arterial pressure


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234

object_name: hypertension


subject: CHEBI:17234

object_name: Hypertension, CTCAE


subject: CHEBI:166975

subject_name: soybean oil


subject: CHEBI:166975


subject: CHEBI:166975


subject: CHEBI:166975


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Pelvis fracture


subject: CHEBI:3215

object_name: Hip Fracture, CTCAE


subject: UNII:F92V3S521O

subject_name: Aluminium phosphate

object_name: Plasmodium falciparum malaria


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: Solid Neoplasm


subject: UMLS:C5706496

subject_name: Anti-TROP-2 Antibody-drug Conjugate DB-1305


subject: UMLS:C5961092

subject_name: Anti-B7-H3 Antibody-drug Conjugate DB-1311


subject: UNII:3ZO554A4Q8

subject_name: Voxelotor

object_name: Sickle cell anemia in children


subject: CHEBI:134674

subject_name: Yosprala

object_name: gastric ulcer


subject: CHEBI:134674

object_name: Gastric Ulcer, CTCAE


subject: UMLS:C5853413

subject_name: Prolactin G129R

object_name: ovarian cancer


subject: UMLS:C5853413

object_name: ovarian neoplasm


subject: UMLS:C5853413

object_name: ovarian carcinoma


subject: UMLS:C5853413

object_name: peritoneum cancer


subject: UMLS:C5853413

object_name: fallopian tube carcinoma


subject: UMLS:C5853413

object_name: fallopian tube cancer


subject: UMLS:C5853414

subject_name: Prolanta


subject: UMLS:C5853414


subject: UMLS:C5853414


subject: UMLS:C5853414


subject: UMLS:C5853414


subject: UMLS:C5853414


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Carcinoma breast stage IV


subject: CHEBI:28261

subject_name: (+)-alpha-pinene

object_name: thrombocytopenia 1


subject: CHEBI:28660

subject_name: (-)-alpha-pinene


subject: CHEBI:36740

subject_name: alpha-Pinene


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: pneumonia childhood


subject: UMLS:C0041044


subject: UNII:AL3G001BI8

subject_name: Ravidasvir

object_name: chronic hepatitis C virus infection


subject: UMLS:C4508633

subject_name: ravidasvir


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: Malignant pleural effusion


subject: DRUGBANK:DB15074


subject: DRUGBANK:DB15074


subject: DRUGBANK:DB15074


subject: DRUGBANK:DB15074

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB15074

object_name: breast carcinoma


subject: DRUGBANK:DB15074

object_name: breast cancer


subject: DRUGBANK:DB15074

object_name: Mesothelioma


subject: DRUGBANK:DB15074

object_name: mesothelial neoplasm


subject: DRUGBANK:DB15074

object_name: malignant mesothelioma


subject: DRUGBANK:DB15074

object_name: lung cancer


subject: DRUGBANK:DB15074

object_name: lung neoplasm


subject: DRUGBANK:DB15074

object_name: lung carcinoma


subject: CHEBI:233453


subject: CHEBI:233453

object_name: ovarian cancer


subject: CHEBI:233453

object_name: ovarian neoplasm


subject: CHEBI:233453

object_name: ovarian carcinoma


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:75179

subject_name: Trifluridine

object_name: biliary tract cancer


subject: CHEBI:75179

object_name: biliary tract neoplasm


subject: CHEBI:75179

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:75179

object_name: gallbladder cancer


subject: CHEBI:75179

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:75179

object_name: gallbladder carcinoma


subject: CHEBI:75179

object_name: cholangiocarcinoma


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:83766

subject_name: Olaparib

object_name: Laryngeal cancer stage III


subject: CHEBI:83766

object_name: Laryngeal cancer stage II


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: adult lymphoma


subject: UMLS:C1314412

object_name: lymphoma


subject: UMLS:C1314412

object_name: pediatric lymphoma


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: PR:000037293

subject_name: sarcoplasmic/endoplasmic reticulum calcium ATPase 2 isoform 2

object_name: Heart failure with normal ejection fraction


subject: PR:000037293

object_name: diastolic heart failure


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Aggressive behavior


subject: CHEBI:36005

object_name: Aggression


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: CHEBI:46662

subject_name: mineral


subject: CHEBI:46662


subject: UMLS:C4529398

subject_name: Multi Vitamin+


subject: UMLS:C4529398


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:9555


subject: UMLS:C5555568

subject_name: Autologous Ovarian Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC

object_name: ovarian cancer


subject: UMLS:C5555568

object_name: ovarian neoplasm


subject: UMLS:C5555568

object_name: ovarian carcinoma


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: COVID-19 respiratory infection


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: UMLS:C0213769

subject_name: BA 679 BR

object_name: COPD, severe early onset


subject: UMLS:C0213769

object_name: chronic obstructive pulmonary disease


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: type 1 diabetes mellitus 1


subject: UNII:DLG4EML025

object_name: type 1 diabetes mellitus


subject: CHEBI:82663

subject_name: elemental iron

object_name: Nutritional status


subject: CHEBI:18248

subject_name: Iron


subject: CHEBI:135530

subject_name: Solifenacin

object_name: post prostatectomy


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Unresectable Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Primary gout


subject: CHEBI:7457

subject_name: Nalmefene

object_name: borderline personality disorder


subject: UMLS:C1541160

subject_name: volociximab

object_name: non-small cell lung carcinoma


subject: GTOPDB:10236


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEBI:30742

subject_name: macrogol

object_name: acute kidney failure


subject: CHEBI:30742

object_name: Acute Kidney Injury, CTCAE


subject: PR:000012224

subject_name: glycodelin


subject: PR:000012224


subject: UNII:MF4P7VQ2K8

subject_name: TAVOKINOGENE TELSEPLASMID

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5700412

subject_name: Tavo


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: alopecia areata


subject: CHEBI:66919

object_name: alopecia


subject: UNII:S7H48S6K7H

subject_name: Troriluzole

object_name: hereditary ataxia


subject: UNII:S7H48S6K7H

object_name: cardiac arrest


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:201431

object_name: Burkitt's lymphoma refractory


subject: CHEBI:201431

object_name: B-cell lymphoma refractory


subject: CHEBI:201431

object_name: Recurrent Burkitt Lymphoma